Paradigm Biocapital Advisors LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
27
Total Value
2172397711
Accession Number
0001855655-25-000007
Form Type
13F-HR
Manager Name
Paradigm Biocapital Advisors LP
Data Enrichment
93% identified
25 identified2 unidentified

Holdings

27 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
Olema Pharmaceuticals, Inc.
Shares:
6741172(-7.7%)
Value:
$25.3B(-40.5%)
MoonLake Immunotherapeutics
Shares:
627423(-64.6%)
Value:
$24.5B(-74.5%)
Arcutis Biotherapeutics, Inc.
Shares:
1465334
Value:
$22.9B
Y-mAbs Therapeutics, Inc.
Shares:
4236346(+0.0%)
Value:
$18.8B(-43.4%)
Erasca, Inc.
Shares:
10802354(+0.5%)
Value:
$14.8B(-45.2%)
OCULAR THERAPEUTIX, INC
Shares:
1314018
Value:
$9.6B
Immatics N.V.
Shares:
1907108(-64.8%)
Value:
$8.6B(-77.7%)